HK1152249A1 - Reduced volume formulation of glatiramer acetate and methods of administration - Google Patents
Reduced volume formulation of glatiramer acetate and methods of administrationInfo
- Publication number
- HK1152249A1 HK1152249A1 HK11106439.3A HK11106439A HK1152249A1 HK 1152249 A1 HK1152249 A1 HK 1152249A1 HK 11106439 A HK11106439 A HK 11106439A HK 1152249 A1 HK1152249 A1 HK 1152249A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- administration
- methods
- reduced volume
- glatiramer acetate
- volume formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27100909P | 2009-07-15 | 2009-07-15 | |
US27134009P | 2009-07-20 | 2009-07-20 | |
US33701110P | 2010-01-29 | 2010-01-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1152249A1 true HK1152249A1 (en) | 2012-02-24 |
Family
ID=42283140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11106439.3A HK1152249A1 (en) | 2009-07-15 | 2011-06-22 | Reduced volume formulation of glatiramer acetate and methods of administration |
Country Status (20)
Country | Link |
---|---|
US (3) | US20110060279A1 (ja) |
EP (2) | EP2275086B1 (ja) |
JP (1) | JP2012533540A (ja) |
AR (1) | AR077484A1 (ja) |
AT (1) | ATE549013T1 (ja) |
AU (1) | AU2010273234A1 (ja) |
BR (1) | BR112012000878A2 (ja) |
CA (1) | CA2697570C (ja) |
DK (1) | DK2275086T3 (ja) |
EA (1) | EA201270167A1 (ja) |
ES (1) | ES2383347T3 (ja) |
HK (1) | HK1152249A1 (ja) |
HR (1) | HRP20120349T1 (ja) |
IL (1) | IL217240A0 (ja) |
MX (1) | MX2012000687A (ja) |
PL (1) | PL2275086T3 (ja) |
PT (1) | PT2275086E (ja) |
RS (1) | RS52367B (ja) |
WO (1) | WO2011008274A2 (ja) |
ZA (1) | ZA201200586B (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2527760T3 (es) * | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
PL2275086T3 (pl) | 2009-07-15 | 2012-09-28 | Teva Pharma | Formulacja octanu glatirameru o zredukowanej objętości oraz sposoby podawania |
US8920373B2 (en) | 2009-07-15 | 2014-12-30 | Teva Pharmaceutical Industries, Ltd. | Reduced volume formulation of glatiramer acetate and methods of administration |
ES2612001T4 (es) | 2009-08-20 | 2018-02-07 | Yeda Research & Development Company, Ltd. | Terapia de baja frecuencia con acetato de glatirámero |
USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
US8759302B2 (en) * | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
NZ609938A (en) | 2010-10-11 | 2015-11-27 | Teva Pharma | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
JP2014530819A (ja) | 2011-10-10 | 2014-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | 酢酸グラチラマーに対する臨床的応答性を予測するために有用な一塩基多形 |
CN104684603B (zh) * | 2012-08-20 | 2017-11-24 | 卡贝欧洲有限公司 | 自动注射装置 |
EP2906719A4 (en) | 2012-10-10 | 2016-11-09 | Teva Pharma | PREDICTIVE BIOMARKER FOR CLINICAL REACTION FOR GLATIRAMERACETATE |
WO2014128079A1 (en) * | 2013-02-19 | 2014-08-28 | Synthon B.V. | Glatiramer acetate multidose formulation |
KR101780191B1 (ko) * | 2013-03-08 | 2017-09-21 | 테바 파마슈티컬 인더스트리즈 리미티드 | 주사기용 재사용 가능한 주입기 장치 |
US8591463B1 (en) | 2013-03-08 | 2013-11-26 | Teva Pharmaceutical Industries Ltd. | Re-useable injector device for syringe |
AU2014224340B2 (en) * | 2013-03-08 | 2016-12-22 | Teva Pharmaceutical Industries Limited | Re-useable injector device for syringe |
UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
RU2728195C2 (ru) | 2014-02-26 | 2020-07-28 | Аллерган, Инк. | Устройство доставки внутриглазного имплантата и способы его использования |
US9415176B1 (en) | 2015-01-22 | 2016-08-16 | West Pharmaceutical Services, Inc. | Autoinjector having an end-of-dose visual indicator |
US9155775B1 (en) * | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
EP3534893A1 (en) * | 2016-11-02 | 2019-09-11 | To Pharmaceuticals LLC | Combination therapy of cbd and copaxone |
EP4252629A3 (en) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
CA3050086A1 (en) | 2017-03-26 | 2018-10-04 | Mapi Pharma Ltd. | Glatiramer depot systems for treating progressive forms of multiple sclerosis |
US10323289B2 (en) | 2017-06-26 | 2019-06-18 | Institut Pasteur | Treatments to eliminate HIV reservoirs and reduce viral load |
US20200306516A1 (en) | 2017-08-14 | 2020-10-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3673317D1 (de) * | 1985-10-11 | 1990-09-13 | Duphar Int Res | Automatische spritze. |
NL8701091A (nl) * | 1987-05-08 | 1988-12-01 | Spruyt Hillen Bv | Injectiepen. |
US5981485A (en) * | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
GB8926825D0 (en) * | 1989-11-28 | 1990-01-17 | Glaxo Group Ltd | Device |
IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
US6454746B1 (en) * | 1997-06-04 | 2002-09-24 | Eli Lilly And Company | Medication delivery apparatus |
US20020077278A1 (en) * | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
SE518981C2 (sv) | 2000-12-14 | 2002-12-17 | Shl Medical Ab | Autoinjektor |
EP1572271A1 (de) * | 2002-11-25 | 2005-09-14 | Tecpharma Licensing AG | Autoinjektor mit rückstellbarer auslösesicherung |
WO2005032482A2 (en) * | 2003-10-03 | 2005-04-14 | Bayhill Therapeutics, Inc. | Treatment of demyelinating autoimmune disease with modified ordered peptides |
US7655221B2 (en) * | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
EP1796710A4 (en) * | 2004-09-02 | 2010-05-26 | Teva Pharma | THERAPY COMBINED WITH GLATIRAMER ACETATE AND N-ACETYLCYSTEINE TO TREAT MULTIPLE SCLEROSIS |
SI1797109T1 (sl) * | 2004-09-09 | 2016-07-29 | Yeda Research And Development Co., Ltd. | Zmesi polipeptidov, sestavki, ki jih vsebujejo, in postopki za njihovo pripravo ter njihove uporabe |
WO2006050122A1 (en) * | 2004-10-29 | 2006-05-11 | Sandoz Ag | Processes for preparing glatiramer |
WO2007081975A2 (en) * | 2006-01-11 | 2007-07-19 | Teva Pharmaceutical Industries, Ltd. | Method of treating multiple sclerosis |
US20070161960A1 (en) * | 2006-01-12 | 2007-07-12 | Fu-Yuan Li | Lancet device |
US20080118553A1 (en) * | 2006-06-12 | 2008-05-22 | Anton Frenkel | Tannate salt form of polypeptide mixtures, their preparation and use |
EP2043711A4 (en) * | 2006-06-30 | 2017-08-30 | AbbVie Biotechnology Ltd | Automatic injection device |
USD622374S1 (en) * | 2006-09-06 | 2010-08-24 | Abbott Biotechnology Ltd. | Automatic injection device |
AU2008330093A1 (en) * | 2007-11-28 | 2009-06-04 | Yeda Research And Development Co., Ltd. | Method of delaying the onset of clinically definite multiple sclerosis |
USD607558S1 (en) * | 2008-09-19 | 2010-01-05 | Becton Dickinson France S.A.S. | Medicine injector |
PL2275086T3 (pl) * | 2009-07-15 | 2012-09-28 | Teva Pharma | Formulacja octanu glatirameru o zredukowanej objętości oraz sposoby podawania |
-
2010
- 2010-04-15 PL PL10160099T patent/PL2275086T3/pl unknown
- 2010-04-15 US US12/761,367 patent/US20110060279A1/en not_active Abandoned
- 2010-04-15 RS RS20120188A patent/RS52367B/en unknown
- 2010-04-15 EP EP10160099A patent/EP2275086B1/en active Active
- 2010-04-15 DK DK10160099.7T patent/DK2275086T3/da active
- 2010-04-15 CA CA2697570A patent/CA2697570C/en not_active Expired - Fee Related
- 2010-04-15 PT PT10160099T patent/PT2275086E/pt unknown
- 2010-04-15 ES ES10160099T patent/ES2383347T3/es active Active
- 2010-04-15 AT AT10160099T patent/ATE549013T1/de active
- 2010-05-21 US US12/785,125 patent/US7855176B1/en not_active Expired - Fee Related
- 2010-07-14 JP JP2012520598A patent/JP2012533540A/ja active Pending
- 2010-07-14 MX MX2012000687A patent/MX2012000687A/es not_active Application Discontinuation
- 2010-07-14 BR BR112012000878A patent/BR112012000878A2/pt not_active IP Right Cessation
- 2010-07-14 AU AU2010273234A patent/AU2010273234A1/en not_active Abandoned
- 2010-07-14 EP EP10800156A patent/EP2453907A2/en not_active Withdrawn
- 2010-07-14 EA EA201270167A patent/EA201270167A1/ru unknown
- 2010-07-14 WO PCT/US2010/001972 patent/WO2011008274A2/en active Application Filing
- 2010-07-15 AR ARP100102598A patent/AR077484A1/es unknown
- 2010-11-17 US US12/948,611 patent/US9018170B2/en not_active Expired - Fee Related
-
2011
- 2011-06-22 HK HK11106439.3A patent/HK1152249A1/xx unknown
- 2011-12-27 IL IL217240A patent/IL217240A0/en unknown
-
2012
- 2012-01-24 ZA ZA2012/00586A patent/ZA201200586B/en unknown
- 2012-04-18 HR HRP20120349AT patent/HRP20120349T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2275086B1 (en) | 2012-03-14 |
JP2012533540A (ja) | 2012-12-27 |
RS52367B (en) | 2012-12-31 |
EP2275086A1 (en) | 2011-01-19 |
DK2275086T3 (da) | 2012-07-09 |
ZA201200586B (en) | 2013-10-30 |
WO2011008274A4 (en) | 2011-11-10 |
AR077484A1 (es) | 2011-08-31 |
HRP20120349T1 (hr) | 2012-07-31 |
WO2011008274A3 (en) | 2011-09-22 |
ATE549013T1 (de) | 2012-03-15 |
CA2697570C (en) | 2011-11-01 |
ES2383347T3 (es) | 2012-06-20 |
US20110066112A1 (en) | 2011-03-17 |
PL2275086T3 (pl) | 2012-09-28 |
WO2011008274A2 (en) | 2011-01-20 |
EA201270167A1 (ru) | 2012-08-30 |
US20110060279A1 (en) | 2011-03-10 |
AU2010273234A1 (en) | 2012-02-23 |
CA2697570A1 (en) | 2010-06-22 |
US7855176B1 (en) | 2010-12-21 |
PT2275086E (pt) | 2012-05-18 |
US9018170B2 (en) | 2015-04-28 |
EP2453907A2 (en) | 2012-05-23 |
IL217240A0 (en) | 2012-02-29 |
BR112012000878A2 (pt) | 2019-09-24 |
MX2012000687A (es) | 2012-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201200586B (en) | Reduced volume formulation of glatiramer acetate and methods of administration | |
IL276157A (en) | Pharmaceutical preparations and methods for transferring them related to them | |
HK1250313A1 (zh) | 穩定的藥物組合物和使用所述組合物的方法 | |
EP2413917A4 (en) | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | |
PL2493474T3 (pl) | Sposoby i kompozycje do podtrzymywanego dostarczania leków | |
GB2478849A8 (en) | Improved pharmaceutical compositions and methods of delivery | |
IL219155A0 (en) | Pharmaceutical formulations of nitrite and uses thereof | |
EP2558077A4 (en) | ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND ALKALINIZING AGENT | |
IL224191A (en) | Compositions of vitamin d and cmc epi-14 analogues | |
EP2649999A4 (en) | USE OF QUINAZOLIN COMPOUND IN THE PREPARATION OF ANTI-FLAVIVIRUS MEDICINE | |
SI2275086T1 (sl) | Formulacija glatiramer acetata z zmanjšanim volumnom in postopki za dajanje | |
GB201012660D0 (en) | Inhaler and formulation |